Literature DB >> 16696813

Determinants of quality of life in chronic liver patients.

J J Gutteling1, R A de Man, S M van der Plas, S W Schalm, J J V Busschbach, A-S E Darlington.   

Abstract

BACKGROUND AND AIM: Health-related quality of life of patients with chronic liver disease has been shown to be impaired in numerous studies. However, the factors which influence health-related quality of life in treated chronic liver patients are not quite known. This is the first study to assess the impact of physical and psychosocial determinants on a weighted score of health-related quality of life in patients with chronic liver disease.
METHODS: The data of 1175 chronic liver patients were used to assess the relationship between items of the disease-specific Liver Disease Symptom Index 2.0 and the Short Form (SF)-6D weighted utility score by means of linear regression analyses.
RESULTS: Health-related quality of life was most strongly related to disease severity (B = -0.029) and joint pain (B = -0.023). Depression (B = -0.014), pain in the right upper abdomen (B = -0.014), decreased appetite (B = 0.014) and fatigue (B = -0.013) were also strongly related to health-related quality of life. In hepatitis C virus patients, disease severity (B = -0.037) and depression (B = -0.030) were strong determinants of health-related quality of life.
CONCLUSIONS: This study shows that health-related quality of life in chronic liver patients is clearly determined by disease severity, joint pain, depression, decreased appetite and fatigue. These patients may benefit most from interventions aimed at improving adaptation to the symptoms described.

Entities:  

Mesh:

Year:  2006        PMID: 16696813     DOI: 10.1111/j.1365-2036.2006.02934.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  33 in total

Review 1.  Evaluation of content on EQ-5D as compared to disease-specific utility measures.

Authors:  Fang-Ju Lin; Louise Longworth; A Simon Pickard
Journal:  Qual Life Res       Date:  2012-06-23       Impact factor: 4.147

2.  Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.

Authors:  Evangelos Kalaitzakis; Maria Benito de Valle; Monira Rahman; Björn Lindkvist; Einar Björnsson; Roger Chapman; Nick Kontodimopoulos
Journal:  Qual Life Res       Date:  2015-10-15       Impact factor: 4.147

3.  Ascites symptom inventory-7 is a valuable tool for evaluating the effectiveness of tolvaptan in patients with cirrhotic ascites.

Authors:  Hideto Kawaratani; Kei Moriya; Tadashi Namisaki; Naotaka Shimozato; Kosuke Kaji; Hiroaki Takaya; Yukihisa Fujinaga; Yasuhiko Sawada; Shinya Sato; Soichiro Saikawa; Takuya Kubo; Takemi Akahane; Hiroshi Fukui; Hitoshi Yoshiji
Journal:  Exp Ther Med       Date:  2020-11-10       Impact factor: 2.447

4.  Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients.

Authors:  Silvia Nardelli; Ilaria Pentassuglio; Chiara Pasquale; Lorenzo Ridola; Federica Moscucci; Manuela Merli; Concetta Mina; Massimo Marianetti; Mariangela Fratino; Chiara Izzo; Carlo Merkel; Oliviero Riggio
Journal:  Metab Brain Dis       Date:  2013-01-08       Impact factor: 3.584

5.  The cognitive profile of depressed patients with cirrhosis.

Authors:  Charmaine A Stewart; Felicity T B Enders; Mary M Mitchell; Donna Felmlee-Devine; Glenn E Smith
Journal:  Prim Care Companion CNS Disord       Date:  2011

6.  An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens.

Authors:  Zobair M Younossi; Maria Stepanova; Linda Henry; Fatema Nader; Sharon Hunt
Journal:  Am J Gastroenterol       Date:  2016-03-29       Impact factor: 10.864

7.  Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network.

Authors:  Kristin David; Kris V Kowdley; Aynur Unalp; Fasiha Kanwal; Elizabeth M Brunt; Jeffrey B Schwimmer
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

8.  Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients.

Authors:  Carlos K H Wong; Elegance T P Lam; Cindy L K Lam
Journal:  Qual Life Res       Date:  2013-04-06       Impact factor: 4.147

9.  Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt.

Authors:  Thomas D Boyer; J Michael Henderson; Adrienne M Heerey; Susana Arrigain; Vicky Konig; Jason Connor; Kareem Abu-Elmagd; John Galloway; Layton F Rikkers; Lennox Jeffers
Journal:  J Hepatol       Date:  2007-10-23       Impact factor: 25.083

10.  Health-related quality of life of Southern Chinese with chronic hepatitis B infection.

Authors:  Elegance T P Lam; Cindy L K Lam; C L Lai; M F Yuen; Daniel Y T Fong; Thomas M K So
Journal:  Health Qual Life Outcomes       Date:  2009-06-05       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.